Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL000500

Drug Information
NameBSI-201
SynonymsSAR-240550; NSC-746045; INO2BA; IND-71677; EN002691; S1087_Selleck; 4-iodo-3-nitro-benzamide; Iniparib, NSC-746045, IND-71677, BSI201, BSI-201; BSI-201; CID9796068; CHEMBL1170047; 160003-66-7; Iniparib; NIBA; EC-000.2329; 4-Iodo-3-nitrobenzamide
CompanySanofi-Aventis
IndicationTriple Negative Breast Cancer
[ICD9: 174, 175   ICD10: C50]
Phase II    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C7H5IN2O3/c8-5-2-1-4(7(9)11)3-6(5)10(12)13/h1-3H,(H2,9,11)
InChIKeyMDOJTZQKHMAPBK-UHFFFAOYSA-N
Canonical SMILESC1=CC(=C(C=C1C(=O)N)[N+](=O)[O-])I    
CAS NumberCAS 160003-66-7
PubChem Compound IDCID 9796068.
PubChem Substance IDSID 14751362.
ClinicalTrials.govNCT00813956;
TargetPARP-1Inhibitor[1]
Ref 1Pharma & Vaccines. Product Development Pipeline. April 29 2009. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543